{"id":"NCT01626820","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral速 (2012/2013 Season) in Adults","officialTitle":"Immunogenicity and Safety Study of GSK Biologicals' Trivalent Split Virion Influenza Vaccine (GSK1536489A) Fluviral速 (2012/2013 Season) in Adults Aged 18 Years and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07-19","primaryCompletion":"2012-08-10","completion":"2012-08-10","firstPosted":"2012-06-25","resultsPosted":"2013-10-14","lastUpdate":"2018-09-07"},"enrollment":113,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Fluviral速","otherNames":[]}],"arms":[{"label":"Fluviral Adults Group","type":"EXPERIMENTAL"},{"label":"Fluviral Elderly Group","type":"EXPERIMENTAL"}],"summary":"This study is designed to test the immunogenicity in terms of Hemagglutination Inhibition (HI) antibodies against each of the three vaccine influenza strains and reactogenicity and safety of Fluviral速 containing the influenza strains recommended for the 2012-2013 season.","primaryOutcome":{"measure":"Haemagglutination Inhibition (HI) Antibody Titers, Against Each of the Vaccine Influenza Virus Strains.","timeFrame":"At Day 0 and Day 21","effectByArm":[{"arm":"Fluviral Adults Group","deltaMin":84.03,"sd":null},{"arm":"Fluviral Elderly Group","deltaMin":40.48,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":19},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":56},"commonTop":["Pain","Fatigue","Headache","Myalgia","Gastointestinal symptoms"]}}